Central injection of morphine stimulates plasma corticosterone and interleukin (IL)- 6 and IL-6 R mRNAs in the pituitary and adrenals in adjuvant-induced arthritis

Journal of Biological Regulators and Homeostatic Agents

Volumn 13, Issue 2, 1999, Pages 103-109

  Zubelewicz, B ^a   Braczkowski, R ^a   Renshaw, D ^a   Harbuz, M S ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Chronic inflammation; Cytokines; In situ hybridization histochemistry; Opioids

Indexed keywords

CORTICOSTERONE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; MORPHINE; SODIUM CHLORIDE;

ADENOHYPOPHYSIS; ADJUVANT ARTHRITIS; ADRENAL CORTEX; ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE RELEASE; HYPOPHYSIS; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; LATERAL BRAIN VENTRICLE; MALE; NONHUMAN; RAT; STRESS;

EID: 0033303335     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Stress and the hypothalamo-pituitary-adrenal axis: Acute and Immunological activation
2. Paradoxical response of hypothalamic CRF mRNA and CRF-41 peptide and adenophyseal POMC mRNA during chronic inflammatory stress
3. Hypothalamo-pituitary responses to acute stress and changes in circulating glucocorticoids during chronic adjuvant-induced arthritis in the rat
4. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of the circadian rhythm during adjuvant-induced arthritis in the rat
5. Bacterial lypopolyssacharide-induced expression of interleukin-6 messenger RNA in the rat hypothalamus, pituitary, adrenal gland and spleen
6. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis
7. The hypothalamic-pituitary-adrenal axis in autoimmunity
8. Central endotoxin induces different patterns of IL-1 beta and IL-6 m. RNA expression and IL-6 secretion in the brain and periphery
9. Interleukin-1, TNF alpha and IL-6 as mediators of cartilage destruction
10. Intracerebroventricular injection of interleukin-1 induces high circulating levels of interleukin-6
11. Central opiate modulation on peripheral IL-6 in rats
12. Identification of interleukin-6 (IL-6) expressing neurons in the cerebellum and hippocampus of normal adult rats
13. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha, and LIF in the rat brain
14. Effects of glucucorticoids and chronic inflammatory stress upon anterior pituitary interleukin-6 mRNA expression in the rat
15. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat
16. Abnormal neuroendocrine immune communications in patients with rheumatoid arthritis
17. Adrenalectomy sensitizes mice to the lethal effect of interleukin-1 and tumour necrosis factor
18. Regulation of interleukin-6 gene expression in rat
19. Expression of IL-6 mRNA in normal rat and human pituitaries and in human pituitary adenomas
20. Expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat adrenal medulla
21. The influence of restraint stress on the expression of mRNAs for IL-6 and IL-6 receptor in the hypothalamus and midbrain of the rat
22. Effect of centrally-administered enkephalins on carageenin-induced paw oedema in rats
23. Effect of mu-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats
24. Proinflammatory effects of morphine in the rat adjuvant arthritis model
25. Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic Lewis rats treated with cyclosporin A and indomethacin
26. Interleukin-6 (IL-6) in adjuvant arthritis of rats and its pharmacological modulation
27. Expression of TGF β in attenuated Salmonella typhimurium: Oral administration leads to the reduction of inflammation, IL-2 and IFN γ, but enhancement of IL-10, in carrageenin-induced oedema in mice
28. Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model
29. Role of IL-4 and IL-10 in murine collagen-induced arthritis. Protective effect of IL-4 and IL-10 treatment in cartilage destruction
30. IL-10 inhibition of the progression of established collagen-induced arthritis